

Solventum shares are rebounding Thursday after activist investor Trian Fund criticized post‑spin performance and urged steps to unlock value.
You can purchase shares of Solventum (NYSE:SOLV) through any online brokerage.
Other companies in Solventum’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), The Cooper Companies Inc (NASDAQ:COO), Align Technology Inc (NASDAQ:ALGN) and Bausch & Lomb Corp (NYSE:BLCO).
Solventum has a consensus price target of $89.13.
The stock price for Solventum (NYSE: SOLV) is $84.55 last updated November 2, 2026 at 7:55 PM EST.
There are no upcoming dividends for Solventum.
Solventum does not have any upcoming earnings scheduled.
There is no upcoming split for Solventum.
Solventum is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business,...